These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice. Vermeer NS, Bajorek BV. J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236 [Abstract] [Full Text] [Related]
23. Effect of blood hematocrit and erythrocyte deformability on adenosine 5'-diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy. Cecchi E, Marcucci R, Paniccia R, Bandinelli B, Valente S, Giglioli C, Lazzeri C, Gensini GF, Abbate R, Mannini L. Am J Cardiol; 2009 Sep 15; 104(6):764-8. PubMed ID: 19733708 [Abstract] [Full Text] [Related]
24. [Hemorrheological changes in ischemic heart disease]. Forconi S, Guerrini M, Pieragalli D, Acciavatti A, Del Bigo C, Galigani C, Di Perri T. Ric Clin Lab; 1983 Sep 15; 13 Suppl 3():195-208. PubMed ID: 6672996 [Abstract] [Full Text] [Related]
25. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery. Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB, Peterson ED, PREVENT IV Investigators. Ann Thorac Surg; 2007 Mar 15; 83(3):993-1001. PubMed ID: 17307447 [Abstract] [Full Text] [Related]
26. Effect of Sclerovit on endothelial dysfunction, hemorheological parameters, platelet aggregation, plasma concentration of homocysteine and progression of atherosclerosis in patients with vascular diseases. Horvath B, Szapary L, Debreceni L, Feher G, Kenyeres P, Fulop A, Battyani I, Toth K. Clin Hemorheol Microcirc; 2009 Mar 15; 42(1):19-28. PubMed ID: 19363237 [Abstract] [Full Text] [Related]
27. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease? Vayá A, Ricart J, Todolí J, Micó L, Contreras T, Aznar J. Clin Hemorheol Microcirc; 2004 Mar 15; 30(3-4):411-4. PubMed ID: 15258375 [Abstract] [Full Text] [Related]
28. Influence of acute alcohol exposure on hemorheological parameters and platelet function in vivo and in vitro. Fehr M, Galliard-Grigioni KS, Reinhart WH. Clin Hemorheol Microcirc; 2008 Mar 15; 39(1-4):351-8. PubMed ID: 18503145 [Abstract] [Full Text] [Related]
29. Hemorheological abnormalities in stable angina and acute coronary syndromes. Lee BK, Durairaj A, Mehra A, Wenby RB, Meiselman HJ, Alexy T. Clin Hemorheol Microcirc; 2008 Mar 15; 39(1-4):43-51. PubMed ID: 18503109 [Abstract] [Full Text] [Related]
30. [The course of hemorheologic parameters in acute cerebral ischemia]. Lechner H, Ott E, Ossama N, Fazekas F. Wien Med Wochenschr; 1986 Mar 15; 136 Spec No():47-9. PubMed ID: 3825171 [Abstract] [Full Text] [Related]
32. The COACH program produces sustained improvements in cardiovascular risk factors and adherence to recommended medications-two years follow-up. Jelinek M, Vale MJ, Liew D, Grigg L, Dart A, Hare DL, Best JD. Heart Lung Circ; 2009 Dec 15; 18(6):388-92. PubMed ID: 19648058 [Abstract] [Full Text] [Related]
33. Correlations in some pathogenetic factors and values of hemorheological parameters in age-related macular degeneration. Michalska-Malecka K, Slowinska L, Dorecka M, Romaniuk W. Clin Hemorheol Microcirc; 2008 Dec 15; 38(3):209-16. PubMed ID: 18239263 [Abstract] [Full Text] [Related]
34. Effects of antihypertensive therapy on hemorheological profiles in female hypertensive patients with initially low or high whole blood viscosity. Muravyov AV, Meiselman HJ, Yakusevich VV, Zamishlayev AV. Clin Hemorheol Microcirc; 2002 Dec 15; 26(2):125-35. PubMed ID: 12082261 [Abstract] [Full Text] [Related]
35. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up. Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici P, Antoniucci D, Abbate R, Gensini GF. Circulation; 2009 Jan 20; 119(2):237-42. PubMed ID: 19118249 [Abstract] [Full Text] [Related]
36. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events. Marcucci R, Paniccia R, Antonucci E, Gori AM, Fedi S, Giglioli C, Valente S, Prisco D, Abbate R, Gensini GF. Am J Cardiol; 2006 Nov 01; 98(9):1156-9. PubMed ID: 17056317 [Abstract] [Full Text] [Related]
37. The effects of Buyang Huanwu Decoction on hemorheological disorders and energy metabolism in rats with coronary heart disease. Wang WR, Lin R, Zhang H, Lin QQ, Yang LN, Zhang KF, Ren F. J Ethnopharmacol; 2011 Sep 01; 137(1):214-20. PubMed ID: 21605653 [Abstract] [Full Text] [Related]
38. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative. Mehta RH, Roe MT, Chen AY, Lytle BL, Pollack CV, Brindis RG, Smith SC, Harrington RA, Fintel D, Fraulo ES, Califf RM, Gibler WB, Ohman EM, Peterson ED. Arch Intern Med; 2006 Oct 09; 166(18):2027-34. PubMed ID: 17030838 [Abstract] [Full Text] [Related]
39. Evaluation of hemorheological risk factor profile in plasmacytoma patients. Ramakrishnan S, Grebe R, Singh M, Schmid-Schönbein H. Clin Hemorheol Microcirc; 1999 Oct 09; 20(1):11-9. PubMed ID: 11185678 [Abstract] [Full Text] [Related]
40. [Platelet aggregation in patients with coronary disease treated with nifedipine]. Tkaczewski W, Goch JH, Kruszyński G, Ryniec A. Pol Tyg Lek; 1999 Oct 09; 45(10-11):219-21. PubMed ID: 2216944 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]